35 related articles for article (PubMed ID: 17656209)
1. Dual FRET molecular beacons for mRNA detection in living cells.
Santangelo PJ; Nix B; Tsourkas A; Bao G
Nucleic Acids Res; 2004 Apr; 32(6):e57. PubMed ID: 15084672
[TBL] [Abstract][Full Text] [Related]
2. Survivin as a potential biomarker in the diagnosis of bladder cancer: A systematic review and meta-analysis.
Zhou Z; Zou L; Guan Y; Jiang L; Liu Y; Zhang X; Huang X; Ren H; Li Z; Niu H; Liao H; Zhang X; Pan H; Rong S; Ma H
Urol Oncol; 2024 May; 42(5):133-143. PubMed ID: 38418270
[TBL] [Abstract][Full Text] [Related]
3. Rapid noninvasive detection of bladder cancer using survivin antibody-conjugated gold nanoparticles (GNPs) based on localized surface plasmon resonance (LSPR).
Jazayeri MH; Aghaie T; Nedaeinia R; Manian M; Nickho H
Cancer Immunol Immunother; 2020 Sep; 69(9):1833-1840. PubMed ID: 32350593
[TBL] [Abstract][Full Text] [Related]
4. Molecular beacons: a novel optical diagnostic tool.
Han SX; Jia X; Ma JL; Zhu Q
Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):139-48. PubMed ID: 23292078
[TBL] [Abstract][Full Text] [Related]
5. Specific survivin dual fluorescence resonance energy transfer molecular beacons for detection of human bladder cancer cells.
Wang ZQ; Zhao J; Zeng J; Wu KJ; Chen YL; Wang XY; Chang LS; He DL
Acta Pharmacol Sin; 2011 Dec; 32(12):1522-8. PubMed ID: 22019956
[TBL] [Abstract][Full Text] [Related]
6. Bladder cancer detection using FISH (UroVysion assay).
Halling KC; Kipp BR
Adv Anat Pathol; 2008 Sep; 15(5):279-86. PubMed ID: 18724101
[TBL] [Abstract][Full Text] [Related]
7. Preliminary study of diagnostic utility of molecular beacons in bladder cancer.
Zhao J; Wang ZQ; Wang XY; Yang XJ; He D
Urology; 2010 Aug; 76(2):512.e8-13. PubMed ID: 20579701
[TBL] [Abstract][Full Text] [Related]
8. Detection of survivin expression in cervical cancer cells using molecular beacon imaging: new strategy for the diagnosis of cervical cancer.
Xue Y; An R; Zhang D; Zhao J; Wang X; Yang L; He D
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):204-8. PubMed ID: 21752529
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
Moussa O; Abol-Enein H; Bissada NK; Keane T; Ghoneim MA; Watson DK
J Urol; 2006 Jun; 175(6):2312-6. PubMed ID: 16697865
[TBL] [Abstract][Full Text] [Related]
10. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
Eissa S; Swellam M; Shehata H; El-Khouly IM; El-Zayat T; El-Ahmady O
J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of survivin mRNA expression in bladder transitional cell carcinomas.
Kitsukawa S; Aoyagi T; Noda K; Ito T; Yamamoto Y; Hosoda S; Otsuru N; Matsumoto T
Hinyokika Kiyo; 2008 Feb; 54(2):101-6. PubMed ID: 18323166
[TBL] [Abstract][Full Text] [Related]
12. Primary application study in early diagnosis of bladder cancer by survivin molecular beacons.
Zhao J; He D; He H; Li L; Zhang LL; Wang XY
Urology; 2007 Jul; 70(1):60-4. PubMed ID: 17656209
[TBL] [Abstract][Full Text] [Related]
13. Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on survivin.
Schultz IJ; Witjes JA; Swinkels DW; de Kok JB
Clin Chim Acta; 2006 Jun; 368(1-2):20-32. PubMed ID: 16480698
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
